pertuzumab and trastuzumab (Phesgo)
Early breast cancer (EBC)In combination with chemotherapy in:• the neoadjuvant treatment of adult patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrence• the adjuvant treatment of adult patients with HER2-positive early breast cancer at high risk of recurrence
Metastatic breast cancer (MBC)In combination with docetaxel in adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-HER2 therapy or chemotherapy for their metastatic disease.
